Marrone Bio Innovations I... (MBII)

AI Score

Unlock

0.80

-0.20 (-20.00%)

At close: Apr 24, 2025, 3:47 PM

Marrone Bio Innovations Cash Flow Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021	Q4 2020	Q3 2020	Q2 2020	Q1 2020	Q4 2019	Q3 2019	Q2 2019	Q1 2019	Q4 2018	Q3 2018	Q2 2018	Q1 2018	Q4 2017	Q3 2017	Q2 2017	Q1 2017	Q4 2016	Q3 2016	Q2 2016	Q1 2016
Period Ending	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019	Dec 31, 2018	Sep 30, 2018	Jun 30, 2018	Mar 31, 2018	Dec 31, 2017	Sep 30, 2017	Jun 30, 2017	Mar 31, 2017	Dec 31, 2016	Sep 30, 2016	Jun 30, 2016	Mar 31, 2016
Net Income	-7.6M	-5.31M	-4.95M	-3.04M	-3.26M	-53	-6.06M	-2.87M	-7.02M	-10.14M	-16.37M	-6.75M	-3.92M	-8.01M	-4.44M	-4.84M	-2.92M	-7.38M	-8.53M	-7.38M	-7.63M	-7.81M	-7.2M	-6.78M	-9.28M
Depreciation & Amortization	1.19M	1.18M	1.15M	1.15M	1.09M	302K	1.08M	1.08M	1.1M	1.13M	724K	651K	654K	463K	444K	505K	478K	504K	506K	513K	521K	539K	546K	556K	594K
Stock-Based Compensation	822K	759K	796K	881K	915K	840K	964K	884K	907K	1.78M	742K	606K	558K	540K	437K	382K	491K	390K	555K	587K	582K	644K	698K	710K	617K
Other Working Capital	-3.22M	1.6M	1.75M	1.03M	-710K	-1.32M	-3.55M	5.18M	-2.13M	-3.11M	2.99M	2.08M	-375K	1.1M	-736K	-754K	-2.39M	695K	-549K	1.59M	1.15M	2.76M	-1.37M	981K	-721K
Other Non-Cash Items	-83K	-793K	142K	317K	-161K	-3.4M	1.22M	-305K	1.21M	1.71M	6.38M	66K	73K	2.52M	85K	111K	-3.53M	560K	769K	393K	333K	339K	410K	381K	334K
Deferred Income Tax	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Change in Working Capital	-2.73M	779K	2.55M	-556K	-3.6M	-5.1M	1.94M	-237K	-2.48M	584K	2.77M	2.43M	-5.02M	1.88M	1.61M	-1.36M	-4.27M	-692K	2.09M	3.61M	-1.36M	331K	737K	1.31M	-1.98M
Operating Cash Flow	-8.4M	-3.39M	-308K	-1.25M	-5.02M	-7.36M	-858K	-1.45M	-6.29M	-4.94M	-5.75M	-3M	-7.65M	-2.61M	-1.86M	-5.2M	-9.75M	-6.62M	-4.61M	-2.28M	-7.55M	-5.96M	-4.81M	-3.83M	-9.71M
Capital Expenditures	-198K	-188K	-361K	-425K	-119K	-101K	-55K	-268K	-135K	-78K	-33K	-69K	-116K	-84K	-18K	-116K	-362K	-458K	-231K	-77K	-83K	-40K	-76K	-44K	-49K
Cash Acquisitions	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Purchase of Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Sales Maturities Of Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Investing Acitivies	n/a	n/a	n/a	n/a	-750K	-350K	n/a	-350K	-538K	-104K	-6.39M	n/a	n/a	n/a	n/a	n/a	n/a	20K	15K	n/a	n/a	n/a	n/a	n/a	n/a
Investing Cash Flow	-198K	-188K	-361K	-425K	-869K	-451K	-55K	-618K	-673K	-182K	-6.43M	-69K	-116K	-84K	-18K	-116K	-362K	-438K	-216K	-77K	-83K	-40K	-76K	-44K	-49K
Debt Repayment	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	-1.67M	8.16M	-1.75M	213K	8.97M	14.68M	-567K	2.4M	10.83M	3.48M	10.6M	-1.05M	3.13M	346K	-844K	13.37M	24.08M	4.11M	-1.68M	10.82M	-194K	-407K	-259K	15.21M	-253K
Financial Cash Flow	-1.67M	8.16M	-1.75M	213K	8.97M	14.68M	-567K	2.4M	10.83M	3.48M	10.6M	-1.05M	3.13M	346K	-844K	13.37M	24.08M	4.11M	-1.68M	10.82M	-194K	-407K	-259K	15.21M	-253K
Net Cash Flow	-10.26M	4.58M	-2.42M	-1.46M	3.08M	6.87M	-1.48M	331K	3.87M	-1.65M	-1.57M	-4.12M	-4.63M	-2.35M	-2.73M	8.05M	13.97M	-2.95M	-6.5M	8.46M	-7.83M	-6.4M	-5.15M	11.34M	-10.01M
Free Cash Flow	-8.59M	-3.58M	-669K	-1.67M	-5.14M	-7.46M	-913K	-1.72M	-6.43M	-5.02M	-5.78M	-3.07M	-7.77M	-2.69M	-1.88M	-5.32M	-10.11M	-7.08M	-4.84M	-2.36M	-7.63M	-6M	-4.89M	-3.87M	-9.76M